Disease | hematopoietic stem cell transplantation |
Phenotype | C0376545|hematologic malignancies |
Sentences | 9 |
PubMedID- 25274211 | Allogeneic hematopoietic stem cell transplantation is performed in patients with hematologic malignancies refractory to chemotherapy. |
PubMedID- 24371781 | Background and objective: the number of infused cd34+cells (cd34+i) has been associated with absolute lymphocyte count (alc) and the outcome undergoing autologous hematopoietic stem cell transplantation (hsct) in patients with hematologic malignancies. |
PubMedID- 20207843 | Iron overload in hematologic malignancies and outcome of allogeneic hematopoietic stem cell transplantation. |
PubMedID- 22780938 | [treatment outcome of allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies not in remission]. |
PubMedID- 22733023 | Genetic variations in t-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies. |
PubMedID- 21787195 | Clinical options after failure of allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies. |
PubMedID- 26282736 | Adoptive immunotherapies after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies. |
PubMedID- 21929286 | Haploidentical hematopoietic stem cell transplantation in hematologic malignancies with g-csf mobilized bone marrow plus peripheral blood stem cells grafts without t cell depletion: a single center report of 29 cases. |
PubMedID- 20390388 | Haploidentical hematopoietic stem cell transplantation to adults with hematologic malignancies: analysis of 66 cases at a single japanese center. |
Page: 1